Displaying 461 - 480 of 1643
Evonik/PeroxyChem, In the Matter of
The Federal Trade Commission authorized an action to block Evonik Industries AG’s proposed $625 million acquisition of PeroxyChem Holding Company, alleging the merger of the chemical companies would substantially reduce competition in the Pacific Northwest and the Southern and Central United States for the production and sale of hydrogen peroxide, a commodity chemical used for oxidation, disinfection, and bleaching.
Axon Enterprise, Inc. and Safariland, LLC; Analysis of Consent Order To Aid Public Comment
FTC Approves Final Order Settling Charges that Merger of Polyurethane Foam Producers Was Anticompetitive
FXI Holdings and Innocor, In the Matter of
Polyurethane foam producers FXI Holdings, Inc. and Innocor, Inc. have agreed to divest polyurethane foam pouring plants in three regional markets to Future Foam, Inc., to settle Federal Trade Commission charges that FXI’s proposed $850 million acquisition of Innocor would violate federal antitrust law. The FTC alleges that the combination of FXI and Innocor would substantially lessen competition for low-density conventional polyurethane foam used in home furnishings in three regional markets: the Pacific Northwest (Oregon and Washington); the Midwest states of Indiana, Michigan, and Ohio; and Mississippi. To remedy the proposed transaction’s anticompetitive effects, the proposed order requires the companies to divest FXI’s foam-pouring plant in Kent, Washington and Innocor’s foam-pouring plants in Elkhart, Indiana and Tupelo, Mississippi to Future Foam no later than 10 days after the close of the acquisition. On April 20, 2020, the Commission voted 5-0 to approve the final order settling the charges.
VieVu’s Former Parent Company Safariland Agrees to Settle Charges That It Entered into Anticompetitive Agreements with Body-Worn Camera Systems Seller Axon
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules (March 2020)
Six More States Join FTC and NY Attorney General’s Case Against Vyera Pharmaceuticals, Martin Shkreli, and Other Defendants
FTC Approves Final Order Imposing Conditions on Veterinary Service Providers Compassion First and National Veterinary Associates
Federal Trade Commission Closes Investigation of Johnson & Johnson’s Proposed Acquisition of TachoSil from Takeda Pharmaceutical Company
Össur Hf.; Analysis of Agreement Containing Consent Order To Aid Public Comment
FTC Imposes Conditions on Össur Hf’s Acquisition of College Park Industries, Inc.
FTC Sues to Unwind Altria’s $12.8 Billion Investment in Competitor JUUL
FTC to Resume Processing HSR Early Termination Requests on March 30
Danaher Corporation; Analysis of Agreement Containing Consent Orders to Aid Public Comment
Federal Trade Commission and Justice Department Announce Expedited Antitrust Procedure and Guidance for Coronavirus Public Health Efforts
FTC Imposes Conditions on Danaher Corporation’s Acquisition of GE Biopharma
Federal Trade Commission Cancels March 18 Workshop on Draft Vertical Merger Guidelines
Premerger Notification Office Implements Temporary e-Filing System
Displaying 461 - 480 of 1643